: Flowchart of patient selection for the study cohort. 250.4, 590.0, 590.2, 590.3, 590.8, 593.0, 593.1, 593.2, 593.6, 593.9, 599.7, 753.0, 753.1, 753.2, 753.3, 753.4, 996.1, V42.0, V45.1, 403, 404, 580-583, 585-589, V56, 405.01, 405.11, 405.91, 405.02, 405.12, 405.92, 593.81, 996.81, 996.73 01Jul1999 to 31Dec2014: ICD-9-CM = International Classification of Diseases, 9 th revision, Clinical Modification (includes procedure codes); ICD-10-AM = International Classification of Diseases, 10 th revision Australian Modification (includes procedure codes). Supplementary Table S3 : Comparison of usage and median adherence for the 4 drug groups between men and women in the study cohort. ‡CHD admission during the landmark period with or without a CARP during the index myocardial infarction admission or within the landmark period. CHD, coronary heart disease; CARP, coronary artery revascularisation procedure; RASI, renin-angiotensin system inhibitor. ‡CHD admission during the landmark period with or without a CARP during the index myocardial infarction admission or within the landmark period. CHD, coronary heart disease; CARP, coronary artery revascularisation procedure; RASI, renin-angiotensin system inhibitor.
Supplementary
E10.2,

